Dave A. Ghatt

Array ( [id] => 4358355 [patent_doc_number] => 06174856 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Stabilized insulin compositions' [patent_app_type] => 1 [patent_app_number] => 9/227053 [patent_app_country] => US [patent_app_date] => 1999-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5825 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174856.pdf [firstpage_image] =>[orig_patent_app_number] => 227053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260846 [patent_doc_number] => 06204285 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Methods and compositions for treating urinary incontinence using enantiomerically enriched (R,R)-glycopyrrolate' [patent_app_type] => 1 [patent_app_number] => 9/214168 [patent_app_country] => US [patent_app_date] => 1998-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6834 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204285.pdf [firstpage_image] =>[orig_patent_app_number] => 214168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4252408 [patent_doc_number] => 06207681 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Methods and compositions for treating urinary incontinence using enantiomerically enriched (R)-trihexyphenidyl' [patent_app_type] => 1 [patent_app_number] => 9/214131 [patent_app_country] => US [patent_app_date] => 1998-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6475 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207681.pdf [firstpage_image] =>[orig_patent_app_number] => 214131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359950 [patent_doc_number] => 06255286 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Depsipeptides and drugs containing the same as the active ingredient' [patent_app_type] => 1 [patent_app_number] => 9/214002 [patent_app_country] => US [patent_app_date] => 1998-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26577 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 306 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255286.pdf [firstpage_image] =>[orig_patent_app_number] => 214002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4271514 [patent_doc_number] => 06245740 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Polyol:oil suspensions for the sustained release of proteins' [patent_app_type] => 1 [patent_app_number] => 9/221181 [patent_app_country] => US [patent_app_date] => 1998-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6474 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245740.pdf [firstpage_image] =>[orig_patent_app_number] => 221181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410158 [patent_doc_number] => 06228839 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Use of keratinocyte growth factor to improve oxidative status' [patent_app_type] => 1 [patent_app_number] => 9/216637 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 7589 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228839.pdf [firstpage_image] =>[orig_patent_app_number] => 216637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183904 [patent_doc_number] => 06150331 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Human growth hormone-containing aqueous pharmaceutical composition' [patent_app_type] => 1 [patent_app_number] => 9/215341 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6759 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150331.pdf [firstpage_image] =>[orig_patent_app_number] => 215341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636302 [patent_doc_number] => 06380357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-04-30 [patent_title] => 'Glucagon-like peptide-1 crystals' [patent_app_type] => B2 [patent_app_number] => 09/209799 [patent_app_country] => US [patent_app_date] => 1998-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9744 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380357.pdf [firstpage_image] =>[orig_patent_app_number] => 09209799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4110937 [patent_doc_number] => 06057422 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Antagonistic analogs of GH-RH inhibiting IGF-I and -II' [patent_app_type] => 1 [patent_app_number] => 9/199381 [patent_app_country] => US [patent_app_date] => 1998-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12892 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 279 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057422.pdf [firstpage_image] =>[orig_patent_app_number] => 199381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949325 [patent_doc_number] => 05977302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Liquid phase process for the preparation of GnRH peptides' [patent_app_type] => 1 [patent_app_number] => 9/195049 [patent_app_country] => US [patent_app_date] => 1998-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 12106 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977302.pdf [firstpage_image] =>[orig_patent_app_number] => 195049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4358387 [patent_doc_number] => 06174858 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Conjugates useful in the treatment of prostate cancer' [patent_app_type] => 1 [patent_app_number] => 9/193365 [patent_app_country] => US [patent_app_date] => 1998-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11749 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 245 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174858.pdf [firstpage_image] =>[orig_patent_app_number] => 193365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4268519 [patent_doc_number] => 06306822 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Phosphopeptides and methods of treating bone diseases' [patent_app_type] => 1 [patent_app_number] => 9/193214 [patent_app_country] => US [patent_app_date] => 1998-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 7399 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306822.pdf [firstpage_image] =>[orig_patent_app_number] => 193214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359233 [patent_doc_number] => 06191109 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Methods of treating intestinal ischemia using heparin-binding epidermal growth factor' [patent_app_type] => 1 [patent_app_number] => 9/181974 [patent_app_country] => US [patent_app_date] => 1998-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6543 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191109.pdf [firstpage_image] =>[orig_patent_app_number] => 181974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4295232 [patent_doc_number] => 06197750 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases' [patent_app_type] => 1 [patent_app_number] => 9/177549 [patent_app_country] => US [patent_app_date] => 1998-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31383 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197750.pdf [firstpage_image] =>[orig_patent_app_number] => 177549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4065584 [patent_doc_number] => 06008199 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Methods for treating hypercoagulable states or acquired protein C deficiency' [patent_app_type] => 1 [patent_app_number] => 9/174507 [patent_app_country] => US [patent_app_date] => 1998-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7674 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008199.pdf [firstpage_image] =>[orig_patent_app_number] => 174507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157478 [patent_doc_number] => 06156729 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Leukemia inhibitory factor for use in modulating inflammation and pain' [patent_app_type] => 1 [patent_app_number] => 9/173433 [patent_app_country] => US [patent_app_date] => 1998-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 9590 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156729.pdf [firstpage_image] =>[orig_patent_app_number] => 173433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237044 [patent_doc_number] => 06143716 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Liposomal peptide-lipid conjugates and delivery using same' [patent_app_type] => 1 [patent_app_number] => 9/168010 [patent_app_country] => US [patent_app_date] => 1998-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 15426 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 274 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143716.pdf [firstpage_image] =>[orig_patent_app_number] => 168010 [rel_patent_id] =>[rel_patent_doc_number] =>)